Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Generation Bio (GBIO) Gains from Investment Securities (2021 - 2025)

Historic Gains from Investment Securities for Generation Bio (GBIO) over the last 5 years, with Q3 2025 value amounting to -$1.4 million.

  • Generation Bio's Gains from Investment Securities fell 15361.4% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.5 million, marking a year-over-year decrease of 29153.12%. This contributed to the annual value of $13.2 million for FY2024, which is 2102.0% up from last year.
  • According to the latest figures from Q3 2025, Generation Bio's Gains from Investment Securities is -$1.4 million, which was down 15361.4% from -$203000.0 recorded in Q2 2025.
  • Over the past 5 years, Generation Bio's Gains from Investment Securities peaked at $35.0 million during Q4 2021, and registered a low of -$2.6 million during Q4 2024.
  • Its 5-year average for Gains from Investment Securities is $1.7 million, with a median of -$251000.0 in 2023.
  • Data for Generation Bio's Gains from Investment Securities shows a peak YoY increase of 144970.06% (in 2022) and a maximum YoY decrease of 81501.98% (in 2022) over the last 5 years.
  • Over the past 5 years, Generation Bio's Gains from Investment Securities (Quarter) stood at $35.0 million in 2021, then plummeted by 99.59% to $144000.0 in 2022, then tumbled by 448.61% to -$502000.0 in 2023, then plummeted by 411.35% to -$2.6 million in 2024, then soared by 43.94% to -$1.4 million in 2025.
  • Its last three reported values are -$1.4 million in Q3 2025, -$203000.0 for Q2 2025, and -$269000.0 during Q1 2025.